Another COVID 19 vaccine may soon arrive in Canada.
Novavax has submitted its COVID-19 vaccine to Health Canada for approval.
The U.S. biotechnology company says its application includes data from a clinical trial that included over 30,000 participants in Mexico and the United States.
The two-dose inoculation is made with lab-grown copies of the spike protein that coats the coronavirus, which differs from mRNA vaccines like Pfizer and Moderna.
Those shots send genetic instructions for the body to create its own spike protein.

'System Navigators' Guide Health Care Decisions
Queen Street Businesses Open: BIA
NRP Looking for Missing Teen... Again
Police Looking for Missing Man
SIU Clears OPP Officer After Collision
Doors Shut on Port Colborne Centre
Premier Pressured for State of Emergency
It's a Big Year for St. Catharines